Carbon monoxide poisoning triggers intestinal injury, inflammation, and microbiota dysbiosis that drive metabolic perturbations

IF 5.2 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Tzu-Hao Chen , Chien-Chin Hsu , Hung-Jung Lin , Chung-Han Ho , Ching-Ping Chang , Chien-Cheng Huang , Ying-Jan Wang
{"title":"Carbon monoxide poisoning triggers intestinal injury, inflammation, and microbiota dysbiosis that drive metabolic perturbations","authors":"Tzu-Hao Chen ,&nbsp;Chien-Chin Hsu ,&nbsp;Hung-Jung Lin ,&nbsp;Chung-Han Ho ,&nbsp;Ching-Ping Chang ,&nbsp;Chien-Cheng Huang ,&nbsp;Ying-Jan Wang","doi":"10.1016/j.lfs.2025.123839","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To determine whether carbon monoxide poisoning (COP) increases the long-term risk of intestinal diseases and to elucidate the underlying mechanisms through translational investigation using both population data and animal experiments.</div></div><div><h3>Materials and methods</h3><div>An epidemiological study using the Taiwan National Health Insurance Research Database identified 11,025 COP patients and matched controls to assess long-term intestinal disease risk. A rat COP model was used to evaluate intestinal injury, permeability, and tight junction integrity. Systemic inflammation and immune cell populations were assessed. Gastrointestinal and stress/metabolic hormones and metabolic markers were measured. Gut microbiota was analyzed by 16S rRNA sequencing, with functional prediction using Tax4Fun and KEGG.</div></div><div><h3>Key findings</h3><div>COP increased long-term intestinal disease risk in humans. Rats showed duodenal and jejunal injury with elevated permeability and barrier disruption. Systemic inflammation (increased CX3CL1, CXCL7, IL1-α/β, CXCL5, CCL20, TIMP-1, CD54) and immune activation (increased CD86<sup>+</sup> macrophages, neutrophils, CD4<sup>+</sup> T cells) were observed. Hormones (decreased cholecystokinin and insulin; increased glucagon-like peptide-1, ghrelin, glucose-dependent insulinotropic polypeptide, cortisol) and metabolism were altered (increased glucose and lipids). Microbiota alterations, including increased <em>Mycoplasma</em>, <em>Streptococcus</em>, and <em>Desulfovibrio</em>, were associated not only with proinflammatory cytokine responses but also with metabolic dysregulation, including lipid imbalance and pathways linked to type II diabetes mellitus.</div></div><div><h3>Significance</h3><div>This study provides the first integrated clinical and experimental evidence linking COP to intestinal and metabolic dysfunction. A pathogenic axis involving gut barrier disruption, microbiota dysbiosis, and metabolic-immune imbalance may underlie COP-related chronic diseases. These findings suggest targets for early monitoring and intervention.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"378 ","pages":"Article 123839"},"PeriodicalIF":5.2000,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320525004746","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

To determine whether carbon monoxide poisoning (COP) increases the long-term risk of intestinal diseases and to elucidate the underlying mechanisms through translational investigation using both population data and animal experiments.

Materials and methods

An epidemiological study using the Taiwan National Health Insurance Research Database identified 11,025 COP patients and matched controls to assess long-term intestinal disease risk. A rat COP model was used to evaluate intestinal injury, permeability, and tight junction integrity. Systemic inflammation and immune cell populations were assessed. Gastrointestinal and stress/metabolic hormones and metabolic markers were measured. Gut microbiota was analyzed by 16S rRNA sequencing, with functional prediction using Tax4Fun and KEGG.

Key findings

COP increased long-term intestinal disease risk in humans. Rats showed duodenal and jejunal injury with elevated permeability and barrier disruption. Systemic inflammation (increased CX3CL1, CXCL7, IL1-α/β, CXCL5, CCL20, TIMP-1, CD54) and immune activation (increased CD86+ macrophages, neutrophils, CD4+ T cells) were observed. Hormones (decreased cholecystokinin and insulin; increased glucagon-like peptide-1, ghrelin, glucose-dependent insulinotropic polypeptide, cortisol) and metabolism were altered (increased glucose and lipids). Microbiota alterations, including increased Mycoplasma, Streptococcus, and Desulfovibrio, were associated not only with proinflammatory cytokine responses but also with metabolic dysregulation, including lipid imbalance and pathways linked to type II diabetes mellitus.

Significance

This study provides the first integrated clinical and experimental evidence linking COP to intestinal and metabolic dysfunction. A pathogenic axis involving gut barrier disruption, microbiota dysbiosis, and metabolic-immune imbalance may underlie COP-related chronic diseases. These findings suggest targets for early monitoring and intervention.

Abstract Image

一氧化碳中毒会引发肠道损伤、炎症和微生物群失调,从而导致代谢紊乱。
目的:通过人群数据和动物实验的转化研究,确定一氧化碳中毒(COP)是否会增加肠道疾病的长期风险,并阐明其潜在机制。材料和方法:一项使用台湾全民健康保险研究数据库的流行病学研究确定了11025名COP患者和匹配的对照组,以评估长期肠道疾病的风险。采用大鼠COP模型评估肠损伤、通透性和紧密连接完整性。评估全身炎症和免疫细胞群。测量胃肠和应激/代谢激素及代谢标志物。采用16S rRNA测序分析肠道菌群,采用Tax4Fun和KEGG进行功能预测。主要发现:COP增加了人类长期肠道疾病的风险。大鼠表现为十二指肠和空肠损伤,渗透性升高,屏障破坏。观察到全身炎症(CX3CL1、CXCL7、il -1 -α/β、CXCL5、CCL20、TIMP-1、CD54升高)和免疫激活(CD86+巨噬细胞、中性粒细胞、CD4+ T细胞升高)。激素(胆囊收缩素和胰岛素减少;胰高血糖素样肽-1、胃饥饿素、葡萄糖依赖性胰岛素性多肽、皮质醇升高)和代谢改变(葡萄糖和脂质升高)。微生物群的改变,包括支原体、链球菌和Desulfovibrio的增加,不仅与促炎细胞因子反应有关,而且与代谢失调有关,包括脂质失衡和与II型糖尿病相关的途径。意义:本研究首次提供了将COP与肠道和代谢功能障碍联系起来的综合临床和实验证据。涉及肠道屏障破坏、微生物群失调和代谢-免疫失衡的致病轴可能是copd相关慢性疾病的基础。这些发现提示了早期监测和干预的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Life sciences
Life sciences 医学-药学
CiteScore
12.20
自引率
1.60%
发文量
841
审稿时长
6 months
期刊介绍: Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed. The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信